News Sentiment

COYA sentiment intelligence

Coya Therapeutics, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 48 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 4.54 Week of 17 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 40

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

-13.7% over one week, -7.7% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Discipline and Rules-Based Execution in COYA Response

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction -13.7% Price reacting lower
Trend fit Trend active -7.7% over four weeks
Fair value -24.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 18
Neutral 28
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 40
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
TradingView 6
dars.gov.et 3
Moomoo 3
Stock Titan 3
simplywall.st 3
Stock Traders Daily 2
Streetwise Reports 2

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 15
Analyst action 5
Guidance 3
Regulatory and legal 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 48
Stock Traders Daily Direct company coverage

Discipline and Rules-Based Execution in COYA Response

This article from Stock Traders Daily discusses the application of discipline and rules-based execution for COYA Therapeutics Inc. (NASDAQ: COYA) using AI models. It highlights three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored to different r

Tone
Neutral 50/100
Event
Market update
Published
22 Jul 2026 13:11
Source
Stock Traders Daily
TradingView Direct company coverage

Price to book forward of Coya Therapeutics, Inc. – NASDAQ:COYA

This article provides the "Price to book forward" value for Coya Therapeutics, Inc. (NASDAQ: COYA). While the specific value is not detailed in the provided content, the article indicates that this financial metric is available for the company on TradingView. It also lists variou

Tone
Neutral 50/100
Event
Market update
Published
19 Jul 2026 11:09
Source
TradingView
Streetwise Reports Direct company coverage

Houston ALS Biotech Coya Eyes 2028 Approval Path

Coya Therapeutics, a Houston-based biotech, is advancing its lead candidate COYA 302 for ALS, with a pivotal Phase 2 trial readout expected in early 2027 and potential conditional approval by the first half of 2028. The company is supported by strong analyst ratings and prominent

Tone
Positive 73/100
Event
Analyst action
Published
16 Jul 2026 20:09
Source
Streetwise Reports
Streetwise Reports Direct company coverage

Coya Targets ALS Trial Readout in Q1 2027, H.C. Wainwright Sets US$18 Price Target

Coya Therapeutics (COYA) is a clinical-stage biopharma company focusing on treatments for ALS and dementia, with multiple analysts giving "Buy" ratings and price targets up to US$18. The company anticipates a significant trial readout in Q1 2027 for its ALS drug, COYA 302, with p

Tone
Positive 70/100
Event
Analyst action
Published
16 Jul 2026 20:09
Source
Streetwise Reports
Moomoo Direct company coverage

Coya Therapeutics(COYA) Stock Options Chain | Quotes & News

This article provides details on Coya Therapeutics (COYA) stock options, including quotes and news. It specifically focuses on the company's financial instruments available for trading.

Tone
Neutral 50/100
Event
Market update
Published
11 Jul 2026 04:12
Source
Moomoo
Stock Traders Daily Direct company coverage

Behavioral Patterns of COYA and Institutional Flows

This article analyzes Coya Therapeutics Inc. (NASDAQ: COYA), highlighting strong near and mid-term sentiment but a weak long-term outlook. It reports an ongoing breakout with potential for higher levels due to no remaining resistance. The analysis provides specific institutional

Tone
Positive 63/100
Event
Guidance
Published
30 Jun 2026 00:24
Source
Stock Traders Daily
TradingView Direct company coverage

Coya Therapeutics, Inc. Actuals & Estimates (NASDAQ:COYA)

This article provides a detailed financial overview and analyst estimates for Coya Therapeutics, Inc. (COYA), covering its income statement, balance sheet, cash flow, and valuation metrics. It highlights the stock's current price performance, analyst forecasts, historical highs a

Tone
Positive 65/100
Event
Analyst action
Published
27 Jun 2026 10:10
Source
TradingView
Stock Titan Direct company coverage

Coya Therapeutics (NASDAQ: COYA) shareholders back board nominees and 2026 auditor

Coya Therapeutics, Inc. (NASDAQ: COYA) shareholders approved the election of two Class I directors, Secretary Wilbur Ross and Dieter Weinand, to three-year terms and ratified Weaver and Tidwell, L.L.P. as the company's independent auditor for the 2026 fiscal year at their Annual

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 21:11
Source
Stock Titan
TradingView Direct company coverage

COYA Forecast — Price Target — Prediction for 2027

This article provides a forecast for Coya Therapeutics, Inc. (COYA) stock, including future price predictions from analysts. It covers various financial metrics, stock performance, market capitalization, and earnings information. The current stock price, historical highs and lows

Tone
Positive 61/100
Event
Earnings
Published
25 Jun 2026 14:11
Source
TradingView
TradingView Direct company coverage

Number of shareholders of Coya Therapeutics, Inc. – NASDAQ:COYA

The article focuses on Coya Therapeutics, Inc. (NASDAQ: COYA), specifically regarding the number of its shareholders. It indicates that the current data is for a specific period and includes value and percentage changes. The information is provided by TradingView, with market dat

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 21:11
Source
TradingView
Barchart.com Direct company coverage

Exosomes Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Innovex Therapeutics, Coya Therapeutics, EV Therapeutics, Endosome Therapy StemXO

The article details the Exosomes Pipeline in 2026, highlighting over 80 companies developing more than 100 exosome treatment therapies, as per DelveInsight's report. It covers emerging therapies in various clinical trial phases, recent advancements such as NurExone's spinal cord

Tone
Positive 66/100
Event
Regulatory and legal
Published
22 Jun 2026 22:41
Source
Barchart.com
Intellectia AI Direct company coverage

COYA Technical Analysis & Stock Price Forecast

This article provides a technical analysis and stock price forecast for Coya Therapeutics Inc (COYA), indicating an overall "Strong Buy" consensus based on various technical indicators. It details the company's performance against moving averages, critical support and resistance

Tone
Positive 71/100
Event
Guidance
Published
22 Jun 2026 08:40
Source
Intellectia AI
TradingKey Direct company coverage

Coya Therapeutics Inc (COYA) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Coya Therapeutics Inc (COYA), focusing on its price momentum, support and resistance levels, and key technical indicators. The stock currently has a price momentum score of 8.62 and is trading between a resistance level of 5.32 and a

Tone
Positive 64/100
Event
Market update
Published
18 Jun 2026 17:39
Source
TradingKey
TradingKey Direct company coverage

Coya Therapeutics Inc (COYA) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on the dividend and stock split history for Coya Therapeutics Inc (COYA). It states that COYA has not distributed any dividends over the past five years and has no recorded stock split events. The page also includes current stock performance metrics

Tone
Neutral 50/100
Event
Capital return
Published
18 Jun 2026 13:09
Source
TradingKey
Business Wire Direct company coverage

Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease

Coya Therapeutics, Inc. (NASDAQ: COYA) will host a virtual webinar on June 24, 2026, at 4 p.m. ET titled "Beyond the Hit: How Repetitive Head Trauma, Inflammation, and Neurodegenerative Disease Intersect." The webinar will feature experts such as Stanley H. Appel, M.D., Fred Gros

Tone
Positive 64/100
Event
Market update
Published
16 Jun 2026 04:11
Source
Business Wire